The Evolution of Targeted Radionuclide Diagnosis of HER2-Positive Breast Cancer

This review examines the evolution of the radionuclide diagnosis of HER2-positive breast cancer using various compounds as a targeting module in clinical practice: from full-length antibodies to a new group of small synthetic proteins called alternative scaffold proteins. This topic is of especial r...

Descripción completa

Detalles Bibliográficos
Autores principales: Bragina, O. D., Deyev, S. M., Chernov, V. I., Tolmachev, V. M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: A.I. Gordeyev 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9307982/
https://www.ncbi.nlm.nih.gov/pubmed/35923562
http://dx.doi.org/10.32607/actanaturae.11611

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9307982/
https://www.ncbi.nlm.nih.gov/pubmed/35923562
http://dx.doi.org/10.32607/actanaturae.11611

Ejemplares similares